Compare NCNO & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NCNO | AXGN |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2022 | 2013 |
| Metric | NCNO | AXGN |
|---|---|---|
| Price | $23.63 | $47.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 9 |
| Target Price | $26.07 | ★ $42.33 |
| AVG Volume (30 Days) | ★ 2.5M | 802.5K |
| Earning Date | 05-27-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 115.15 | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $594,781,000.00 | $225,208,000.00 |
| Revenue This Year | $9.53 | $20.57 |
| Revenue Next Year | $8.97 | $16.68 |
| P/E Ratio | $127.56 | ★ N/A |
| Revenue Growth | 10.01 | ★ 20.21 |
| 52 Week Low | $13.80 | $15.27 |
| 52 Week High | $31.23 | $52.91 |
| Indicator | NCNO | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 72.58 | 49.34 |
| Support Level | $22.81 | $29.48 |
| Resistance Level | $26.21 | $52.91 |
| Average True Range (ATR) | 0.95 | 2.30 |
| MACD | 0.15 | -0.40 |
| Stochastic Oscillator | 89.30 | 31.55 |
Ncino Inc is a provider of cloud-based software for financial institutions. It is focused on developing the nCino Platform to transform commercial and small business lending for community and regional banks in the U.S. With the company's platform financial institutions can Operate More Intelligently, Improve Efficiency, Elevate Employee and Client Experiences, and Manage Risk and Compliance Continuously Rather Than Reactively. It has built and acquired technology, including SimpleNexus, DocFox, FullCircl, ILT, Visible Equity, FinSuite, and Sandbox Banking, to augment the nCino Platform's capabilities for mortgage lending, onboarding, account opening, indirect auto lending, and analytics and AI. The company operates as one operating segment.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.